Suppr超能文献

全身磁共振成像可为弥漫性大B细胞淋巴瘤提供准确的分期,但患者对此的接受度较低。

Whole-body magnetic resonance imaging provides accurate staging of diffuse large B-cell lymphoma, but is less preferred by patients.

作者信息

Lambert Lukas, Wagnerova Monika, Vodicka Prokop, Benesova Katerina, Zogala David, Trneny Marek, Burgetova Andrea

机构信息

Department of Imaging Methods, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague 15006, Czech Republic.

Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 12808, Czech Republic.

出版信息

World J Radiol. 2025 Jan 28;17(1):99207. doi: 10.4329/wjr.v17.i1.99207.

Abstract

BACKGROUND

Whole-body magnetic resonance imaging (wbMRI) allows general assessment of systemic cancers including lymphomas without radiation burden.

AIM

To evaluate the diagnostic performance of wbMRI in the staging of diffuse large B-cell lymphoma (DLBCL), determine the value of individual MRI sequences, and assess patients' concerns with wbMRI.

METHODS

In this single-center prospective study, adult patients newly diagnosed with systemic DLBCL underwent wbMRI on a 3T scanner [diffusion weighted images with background suppression (DWIBS), T2, short tau inversion recovery (STIR), contrast-enhanced T1] and fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) (reference standard). The involvement of 12 nodal regions and extranodal sites was evaluated on wbMRI and PET/CT. The utility of wbMRI sequences was rated on a five-point scale (0 = not useful, 4 = very useful). Patients received a questionnaire regarding wbMRI.

RESULTS

Of 60 eligible patients, 14 (23%) were enrolled and completed the study. The sensitivity of wbMRI in the nodal involvement (182 nodal sites) was 0.84, with 0.99 specificity, positive predictive value of 0.96, negative predictive value of 0.97, and 0.97 accuracy. PET/CT and wbMRI were concordant both in extranodal involvement (13 instances) and staging (κ = 1.0). The mean scores of the utility of MRI sequences were 3.71 ± 0.73 for DWIBS, 2.64 ± 0.84 for T1, 2.14 ± 0.77 for STIR, and 1.29 ± 0.73 for T2 ( < 0.0001). Patients were mostly concerned about the enclosed environment and duration of the MRI examination (27% of patients).

CONCLUSION

The wbMRI exhibited excellent sensitivity and specificity in staging DLBCL. DWIBS and contrast-enhanced T1 were rated as the most useful sequences. Patients were less willing to undergo wbMRI as a second examination parallel to PET/CT, especially owing to the long duration and the enclosed environment.

摘要

背景

全身磁共振成像(wbMRI)可对包括淋巴瘤在内的全身性癌症进行全面评估,且无辐射负担。

目的

评估wbMRI在弥漫性大B细胞淋巴瘤(DLBCL)分期中的诊断性能,确定各MRI序列的价值,并评估患者对wbMRI的顾虑。

方法

在这项单中心前瞻性研究中,新诊断为全身性DLBCL的成年患者在3T扫描仪上接受wbMRI检查[背景抑制扩散加权成像(DWIBS)、T2、短tau反转恢复序列(STIR)、增强T1]以及氟代脱氧葡萄糖(F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)(参考标准)。在wbMRI和PET/CT上评估了12个淋巴结区域和结外部位的受累情况。根据五分制量表(0 = 无用,4 = 非常有用)对wbMRI序列的效用进行评分。患者接受了关于wbMRI的问卷调查。

结果

60例符合条件的患者中,14例(23%)入组并完成了研究。wbMRI对淋巴结受累(182个淋巴结部位)的敏感性为0.84,特异性为0.99,阳性预测值为0.96,阴性预测值为0.97,准确性为0.97。PET/CT与wbMRI在结外受累(13例)和分期方面均一致(κ = 1.0)。MRI序列效用的平均评分:DWIBS为3.71±0.73,T1为2.64±0.84,STIR为2.14±0.77,T2为1.29±0.73(<0.0001)。患者最担心的是MRI检查的封闭环境和检查时长(27%的患者)。

结论

wbMRI在DLBCL分期中表现出优异的敏感性和特异性。DWIBS和增强T1被评为最有用的序列。患者不太愿意接受与PET/CT并行的第二次wbMRI检查,尤其是因为检查时间长和封闭环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b9/11755907/cce595482614/99207-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验